Salmeterol/fluticasone propionate (50/500 μg) in combination in a Diskus® inhaler (Seretide®) is effective and safe in the treatment of steroid-dependent asthma

Respiratory Medicine

Volumn 93, Issue 12, 1999, Pages 876-884

  Aubier, M ^a   Pieters, W R ^b   Schlosser N J J ^c   Steinmetz, K O ^d  

^a BICHAT HOSPITAL   (France)

^b ELKERLIEK HOSPITAL   (Netherlands)

^c CENTRAL MILITARY HOSPITAL   (Netherlands)

^d NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; BUDESONIDE; CORTICOSTEROID; FLUTICASONE PROPIONATE; HYDROCORTISONE; PLACEBO; SALMETEROL; SALMETEROL PLUS FLUTICASONE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTHMA; BREATHING DISORDER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHONIA; FEMALE; HEADACHE; HOARSENESS; HUMAN; HYDROCORTISONE BLOOD LEVEL; INHALER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PEAK EXPIRATORY FLOW; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; STATISTICS; THROAT DISEASE;

EID: 0033403842     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90053-7     Document Type: Article

References (29)

1. Juniper EF, Kline PA, Vanzieleghem MA, et al. Effect of long-term treatment with inhaled steroids on airway hyperresponsiveness and clinical asthma in non-steroid dependant asthmatics. Am Rev Respir Dis 1990; 142: 832-836.
2. Fabbri L, Burge PS, Croonenborgh L, et al. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group. Thorax 1993; 48: 817-823.
3. Blom MW, De Sommers K. Comparative pharmacology of salmeterol and formoterol and their interaction with salbutamol in healthy volunteers. Clin Drug Invest 1997; 14: 400-404.
4. Brogden RN, Faulds D. Salmeterol xinafoate. A review of its pharmacological properties and therapeutic potential in reversible obstructive airways disease. Drugs 1991; 42: 895-912.
5. International consensus report on the diagnosis and management of asthma. Clin Exp Allergy 1992; (Suppl): 1-72.
6. Guidelines on the management of asthma. Thorax 1993; (Suppl): S1-S24.
7. Recommendations in the pharmacological treatment of bronchial asthma II. Pul Medical Products Agency, Uppsala, Sweden 1993; 173-186.
8. British Thoracic Society. The British Guidelines on Asthma Management. Thorax 1997; 52 (Suppl. 1): S1-S21.
9. Global strategy for asthma management and prevention. WHO/NHLBI Workshop Report. National Institutes of Health, National Heart, Lung and Blood Institute, Publication Number 95-3659, 1995.
10. Ullman A, Svedmyr N. Salmeterol, a new long-acting inhaled beta 2-adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients. Thorax 1988; 43: 674-678.
11. Dahl R, Earnshaw JS, Palmer JDB. Salmeterol - four week study of a long-acting beta-adrenoceptor agonist for the treatment of reversible airways disease. Eur Respir J 1991; 4: 1178-1184.
12. Britton MG, Earnshaw JS, Palmer JDB. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992; 5: 1062-1067.
13. Pearlman DS, Chervinsky C, LaForce JM, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992; 327: 1420-1425.
14. Palmer JDB, Stuart AM, Shepherd GL, et al. Inhaled salmeterol in the treatment of patients with moderate-to-severe reversible obstructive airways disease - a three month comparison of the efficacy and safety of twice daily salmeterol. Respir Med 1992; 86: 409-417.
15. Greening AP, Ind PW, Northfield M, et al. Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing corticosteroid. Lancet 1994; 344: 219-224.
16. Woolcock A, Lundback B, Ringdal, N, et al. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids. Am J Respir Crit Care Med 1996; 154: 1481-1488.
17. Ind PW, Dal Negro R, Colman NC, et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma I: Lung function and symptoms. Am J Respir Crit Care Med 1998; 157: A416.
18. Ind PW, Dal Negro R, Colman NC, et al. Inhaled fluticasone propionate and salmeterol in moderate adult asthma II: Exacerbations. Am J Respir Crit Care Med 1998; 157: A415.
19. Eisen SA, Miller DK. Woodward RS, et al. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med 1990; 150: 1881-1884.
20. Coutts JAP, Gibson NA, Paton JY. Measuring compliance with inhaled medication in asthma. Arch Dis Child 1992; 67: 332-333.
21. Derendorf H. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety. Respir Med 1997; 91 (Suppl): 22-28.
22. Dahl R, Lundback B, Malo JL, et al. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993; 104: 1352-1358.
23. Barnes NC, Marone G, Di Maria, et al. On behalf of an International Study Group. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dripropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir J 1993; 6: 877-884.
24. Ayres JG, Bateman ED, Lundbäck B, Harris TAJ. High dose fluticasone propionate, 1 mg daily, versus fluticasone propionate, 2 mg daily, or budesonide, 1·6 mg daily, in patients with chronic severe asthma. Eur Respir J 1995; 8: 579-586.
25. Langdon CG, Capsey LJ. Fluticasone propionate and budesonide in adult asthmatics: a comparison using dry-powder inhaler devices. Br J Clin Res 1994; 5: 85-99.
26. Bateman ED, Britton M, Carrillo J, Almedia J, Wixon C. Salmeterol/fluticasone combination inhaler: a new, effective and well tolerated treatment for asthma. Clin Drug Invest 1998; 16: 193-201.
27. Chapman KR, Ringdal N, Backer V, et al. Salmeterol and fluticasone propionate (50/250 μg) administered via combination Diskus inhaler: as effective as when given via separate Diskus inhalers. Can Resp J 1999; 6: 45-51.
28. Boulet LP, Cowie R, Johnston P, et al. Comparison of Diskus inhaler, a new multidose powder inhaler, with Diskhaler inhaler for the delivery of salmeterol to asthmatic patients. Canadian Study Group. J Asthma 1995; 32: 429-436.
29. Position statement - Safety and appropriate use of salmeterol in the treatment of asthma. J Allergy Clin Immunol 1996; 98: 475-480.